Adrenomyeloneuropathy

Search Trials
A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Status:
Active, not recruiting
Last Changed:
Jul 4, 2019
First Changed:
Jul 11, 2013
Disease(s):
Cerebral Adrenoleukodystrophy (CALD)
Intervention(s):
Lenti-D Drug Product

Connect. Empower. Inspire.